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Introduction:   
Bone substitute materials are increasingly being used, especially in oncologic 
surgery, traumatology, revision prosthetic surgery and in spinal surgery. Over 
two million bone grafting procedures are performed every year, and bone 
substitute materials are often used due to their excellent biocompatibility, 
improved safety profiles, low cost, time advantages and adaptability to a variety 
of clinical challenges. Replacement of autograft by bone graft substitutes   
reduces donor site morbidity. However a limitation with current calcium 
phosphate (CaP) bone substitute materials is that they exist in a dry granular 
form, limiting its handling ability during surgery. Recently, injectable and 
moldable forms of bone substitute material, such as pastes and putties, have been 
developed as they offer many advantages including increased handling ability 
and are able to completely fill contained defects of complex geometric shapes. 
In addition and with the development of minimally invasive surgical methods, 
the requirement to treat bony defects with directly injectable biomaterials is 
increasing. This study investigated the effect of using carboxy-methyl cellulose 
(CMC) as the binding agent on bone formation within a porous silicate-
substituted CaP (SiCaP) scaffold implanted in an ovine femoral condyle critical-
sized defect. Our hypothesis was that CMC would have no negative effect on 
bone formation and osteoconduction within the scaffold. 
 
Methods:  
     Twenty-four 8 x 15 mm deep defects were created in the medial femoral 
condyles of 6 female, skeletally mature commercially cross-bred sheep. Ethical 
approval was granted and all procedures were carried out in compliance with the 
UK’s Home Office Regulations (Animal Scientific Procedures Act 1986).  
Defects were (1) empty, or filled with either (2) SiCaP granules, (3) SiCaP Putty 
or (4) a SiCaP press-fit block.  Implants remained in vivo for 28, 56 and 84 days 
(n=6). Scaffolds in each group were identical in composition and consisted of a 
phase pure SiCaP (0.8 wt % Si) with a total macroporosity of 80%, a 
microporosity of 22.5% and mean pore size of 300 μm. The SiCaP granules used 
in groups 2 and 3 were identical and the groups differed only by the addition of 
CMC. Fluorochrome markers (oxytetracycline and calcein green) were 
administered in order to measure bone apposition rates and following retrieval, 
specimens were processed for undecalcified histology.  A histological section 
was made through the centre of each defect and image analysis techniques were 
used to quantify bone apposition rates, bone area within the graft, bone-implant 
contact and the amount of graft area remaining at 28, 56 and 84 days post 
surgery.  Mann Whitney U tests were used for statistical analysis where p<0.05 
was considered significant. 
 
Results:   
No new bone growth was measured within any of the empty defects at the 28, 56 
and 84 days post-operative time points. Bone Apposition Rates: At 28 days, 
although the greatest bone apposition rates were measured in the SiCaP granules 
group (1.02 ± 0.49 μm/day-1), no significant differences were found when each 
of the groups were compared.  At 56 days post surgery, significantly increased 
bone apposition rates were measured in the SiCaP putty group (2.22 ± 0.22 
μm/day-1) when compared with the SiCaP granules group (1.79 ± 0.17 μm/day-1; 
p = 0.046).  In addition, significantly greater apposition rates were measured in 
the SiCaP block group (1.91 ± 0.39 μm/day-1) when compared with the SiCaP 
granules group.  At 84 days post operatively, no significant differences were 
observed when the granules, putty and block groups were compared.  
Bone Area:  At 28 days significantly increased bone area was measured within 
defects containing SiCaP granules (3.97 ± 1.11%) when compared with both 
SiCaP Putty (0.09 ± 0.06%; p = 0.028) and SiCaP block scaffolds (0.15 ± 
0.08%; p = 0.028) (Figure 1).  This trend continued with significantly increased 
bone formation measured within the SiCaP granules group at 56 days  (20.14 ± 
4.91%) when compared with both the SiCaP Putty (5.47 ± 1.46%; p = 0.046) 
and SiCaP block (6.69 ± 2.10%; p = 0.046) groups.  At 84 days post surgery, 
significantly more  bone was measured in the SiCaP granules group (40.56 ± 
3.73%) when compared with SiCaP blocks (15.38 ± 5.30%; p = 0.028).  No 
other significant differences were found.  Longitudinal analysis showed that in 
all groups, apart from the empty defect bone area significantly increased from 28 
to 84 days  
 
Figure 1: %Bone area measured within scaffolds in each of the 
experimental groups at 4, 8 and 12 weeks. 
 
Bone-Implant Contact:  At 28 days, results showed significantly increased 
bone-implant contact in the SiCaP granules group (10.25 ± 3.05%) when 
compared with both the SiCaP Putty (0.63 ± 0.63% p = 0.028) and SiCaP block 
group (1.05 ± 0.45%; p = 0.028) (Figure 2).  At 56 days post surgery, 
significantly increased bone-implant contact was measured in the SiCaP 
granules (42.03 ± 9.46%) group when compared with defects containing SiCaP 
Putty (17.22 ± 3.61%; p = 0.046).  At 84 days significantly increased bone-
implant contact was measured in the SiCaP granules group (70.84 ± 6.66%) 
when compared with the SiCaP block specimens (37.53 ± 7.73%; p = 0.028).  
No other significant differences were found. Longitudinal analysis showed that 
in all groups, significantly increased amounts of bone-implant contact was 
measured over each time point (except in the empty defects and SiCaP blocks 
between 56 and 84 days time points).  
Graft Area: Significantly reduced graft resorption was measured within defects 
in the SiCaP granules group when compared with the SiCaP Putty and SiCaP 
block groups at 28,56 and 84 days post surgery (p < 0.05 in all cases).  Results 
from this study showed a trend where implant area gradually decreased in all 
groups over time, however, no significant differences within groups was 
observed.  The highest rate of implant resoprtion was measured in the SiCaP 
granule group. 
 
Figure 2: %Bone-Implant Contact measured within scaffolds in each of the 
experimental groups at 4, 8 and 12 weeks. 
 
Discussion  
Greatest amounts of bone formation and bone-implant contact was seen in the 
SiCaP granules group at all of the time points investigated.  Results showed that 
CaP granules augmented increased amounts of bone formation when compared 
with a press-fit block composed of the same material.  This was possibly due to 
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the increased surface area associated with the granules and subsequent increased 
scaffold resorption.  Results from this study also showed the detrimental effect 
that carboxy-methyl cellulose has on bone growth and osteoconduction to a 
SiCaP scaffold. Further research is necessary to optimise CMC when used to 
bind SiCaP granules in the augmentation of bone.   
 
Significance:  Using CMC as a carrier for the application of bone graft 
substitute resulted in significantly reduced bone formation and bone-implant 
contact. CMC putty for bone graft substitutes should be used with caution.    
 
 
 
